Protein Microarray Companies
Protein microarrays are powerful tools in proteomics, allowing researchers to study interactions between proteins, identify protein biomarkers, and analyze protein expression patterns.
Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Latest Protein Microarray Companies Update
October 2023: A new platform for the analysis of autoantibodies linked to disease diagnosis and therapeutic intervention, i-Ome Discovery, has been launched by Sengenics Corporation LLC, a pioneer in immune response profiling that supports scientific discovery and diagnostic development. Researchers in the fields of academia and clinical biopharmaceutics are using the i-Ome Discovery platform to help them better comprehend the complex web of linkages and interactions that exists among proteins, the immune system, and illness. In order to identify autoantibodies with unprecedented sensitivity, specificity, and repeatability, i-Ome Discovery makes use of Sengenics' proprietary KREX® technology. This technique provides completely functioning, full-length autoantigen proteins that have been correctly folded.
September 2023: Tuning Fork Bio Inc. was founded in USA by Yamaha Motor Co., Ltd. The company's goal is to use antibody profiling to better understand people's health situations by analyzing blood antibodies. The United States and Japan are the primary focus areas for this new business. With the help of Tuning Fork Bio's cutting-edge antibody analysis technology, a patient's present health state may be studied through antibody profiling. This process involves selecting antibodies, which are proteins, that are associated with various diseases and comparing them with the patient's own antibodies. Medical institutions' health screenings, patients' medication selection, and pharmaceutical corporations' research into new pharmaceuticals will all profit from this data. An individual's antibody repertoire may be searched exhaustively by comparing the microarray's protein binding states with those of the antibodies in the blood.
List of Protein Microarray Key companies in the market
- Thermo Fisher Scientific (U.S)
- Agilent Technologies (U.S.)
- Hoffmann-La Roche AG (Genentech) (Switzerland)
- Illumina Inc. (U.S.)
- Abbott Laboratories (U.S.)
- PerkinElmer Inc. (U.S.)
- Fluidigm Corporation (U.S.)
- GE Healthcare (U.S.)
- Bio-Rad Laboratories Inc. (U.S.)
- Cepheid Inc. (U.S.)
- SEQUENOM, Inc. (U.S.)
- Sigma Aldrich Corporation (U.S.)
- Affymetrix, Inc. (U.S.)
- EMD Millipore (U.S.)
- Medtronic Inc. (U.S.)
- Angioscore Ltd. (U.S.)
Protein Microarray Market Highlights:
Protein Microarray Market Highlights:
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
